Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Study on Plasmablastic Lymphoma Patients

An International Multicenter Observational Retrospective Study on Plasmablastic Lymphoma Patients

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This is an observational, multicenter, international and retrospective study, that aims to collect data on clinical and pathological characteristics, treatment regimens, outcome, and prognostic factors (clinical, biomarkers and/or radio-metabolic) in patients affected by PBL.

Who May Be Eligible (Plain English)

Who May Qualify: - Diagnosis of plasmablastic lymphoma (PBL) between Jan 1st 2000, and Dec 31st 2022 - diagnosed by tissue sample (biopsy-confirmed) plasmablastic lymphoma (PBL) diagnosis according to local pathological report - Age \> 18 years old - Availability of complete medical records - Availability of histopathological material requested by the study Who Should NOT Join This Trial: - Any other histology than PBL - Lack of complete medical records - Lack of histopathological material requested by the study Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Diagnosis of plasmablastic lymphoma (PBL) between Jan 1st 2000, and Dec 31st 2022 * Histologically confirmed plasmablastic lymphoma (PBL) diagnosis according to local pathological report * Age \> 18 years old * Availability of complete medical records * Availability of histopathological material requested by the study Exclusion Criteria: * Any other histology than PBL * Lack of complete medical records * Lack of histopathological material requested by the study

Locations (20)

IRCCS Centro di Riferimento Oncologico di Aviano, Divisione di Oncologia e dei Tumori immuno-correlati
Aviano, PN, Italy
Ospedale C.e G. Mazzoni, U.O.C. di Ematologia
Ascoli Piceno, Italy
ASST Spedali Civili di Brescia, Ematologia
Brescia, Italy
A.O. S. Croce e Carle, S.C. di Ematologia e Trapianto di Midollo Osseo
Cuneo, Italy
Azienda Ospedaliera Universitaria Careggi, Unità funzionale di Ematologia
Florence, Italy
ASST -Fatebenefratelli - Polo Luigi Sacco Oncologia
Milan, Italy
ASST Grande Ospedale Metropolitano Niguarda, SC Ematologia
Milan, Italy
Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia
Milan, Italy
Ospedale Maggiore Policlinico - Fondazione IRCCS Ca' Granda, Ematologia
Milan, Italy
Fondazione IRCCS San Gerardo dei Tintori, Ematologia
Monza, Italy
AOU Maggiore della Caritа di Novara, SCDU Ematologia
Novara, Italy
Azienda Ospedaliera Universitaria di Padova, Ematologia
Padova, Italy
Presidio ospedaliero A. Tortora, U.O. Onco-ematologia
Pagani, Italy
Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova, Ematologia
Reggio Emilia, Italy
Azienda Ospedaliera Universitaria Sant' Andrea, Ematologia
Roma, Italy
Policlinico Umberto I - Università La Sapienza, Istituto Ematologia, Dipartimento di Medicina Traslazionale e di Precisione
Roma, Italy
Universitа Cattolica S. Cuore, Ematologia
Roma, Italy
Azienda Ospedaliero Universitaria Senese, U.O.C. Ematologia
Siena, Italy
A.O.U. Città della Salute e della Scienza di Torino, Ematologia Universitaria
Torino, Italy
A.O.U. Città della Salute e della Scienza di Torino, S.C. Ematologia
Torino, Italy